Find Faculty
Nina Bhardwaj, MD, PhD
img_Nina Bhardwaj
PROFESSOR | Medicine, Hematology and Medical Oncology
PROFESSOR | Urology
PROFESSOR | Immunology & Immunotherapy
email
Research Topics
AIDS/HIV, Immunology
Multi-Disciplinary Training Area
Immunology [IMM]

MD, New York University School of Medicine

PhD, New York University School of Medicine

Internship, Brigham and Womens Hospital, Harvard Medical School,

New award

326
Publications

Selected Publications

PGV001, a Multi-Peptide Personalized Neoantigen Vaccine Platform: Phase I Study in Patients with Solid and Hematologic Malignancies in the Adjuvant Setting. Mansi Saxena, Thomas U. Marron, Julia Kodysh, John P. Finnigan, Sayali Onkar, Anna Kaminska, Kevin Tuballes, Ruiwei Guo, Rachel Lubong Sabado, Marcia Meseck, Timothy J. O’donnell, Robert P. Sebra, Samir Parekh, Matthew D. Galsky, Ana Blasquez, Gustavo Gimenez, Mesude Bicak, Cansu Cimen Bozkus, Daniela Delbeau-Zagelbaum, Denise Rodriguez, Ana Acuna-Villaorduna, Krzysztof J. Misiukiewicz, Marshall R. Posner, Brett A. Miles, Hanna Y. Irie, Amy Tiersten, Deborah B. Doroshow, Andrea Wolf, John Mandeli, Rachel Brody, Andres M. Salazar, Sacha Gnjatic, Jeff Hammerbacher, Eric Schadt, Philip Friedlander, Alexander Rubinsteyn, Nina Bhardwaj. Cancer Discovery

Clinical and Translational Results from PORTER, a Multicohort Phase I Platform Trial of Combination Immunotherapy in Metastatic Castration-Resistant Prostate Cancer. Matthew D. Galsky, Karen A. Autio, Christopher R. Cabanski, Kristopher Wentzel, Julie N. Graff, Terence W. Friedlander, Timothy R. Howes, Kristin M. Shotts, Julie Densmore, Marko Spasic, Diane M. Da Silva, Richard O. Chen, Jennifer Lata, Jeffrey Skolnik, Tibor Keler, Michael J. Yellin, Theresa M. LaVallee, Justin Fairchild, Silvia Boffo, Jill O’Donnell-Tormey, Ute Dugan, Nina Bhardwaj, Sumit K. Subudhi, Lawrence Fong. Clinical Cancer Research

MTOR inhibition modulates vaccine-induced immune responses to generate memory T cells in patients with solid tumors. Henry G. Withers, Junko Matsuzaki, Mark Long, Spencer R. Rosario, Thinle Chodon, Takemasa Tsuji, Richard Koya, Li Yan, Jianming Wang, Tibor Keler, Shashikant B. Lele, Emese Zsiros, Amit Lugade, Alan Hutson, Stephanie Blank, Nina Bhardwaj, Protul Shrikant, Song Liu, Kunle Odunsi. Journal for ImmunoTherapy of Cancer

View All Publications

Cancer Precision Medicine Retreat -- Session 2: Nina Bhardwaj

Hess CSM Building

1470 Madison Ave

New York, NY 10029

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Bhardwaj during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

  • Merck & Co., Inc.
  • carisma
  • curevac
  • Cell BioEngines
  • apriicty
  • Aikium

Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)

  • genotwin
  • Cell BioEngines
  • apriicty
  • primevax
  • Breakbio

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.